Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)DivestmentsFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BridgeBio Pharma (BBIO) Change in Intangibles: 2024-2025

Historic Change in Intangibles for BridgeBio Pharma (BBIO) over the last 2 years, with Sep 2025 value amounting to $2.4 million.

  • BridgeBio Pharma's Change in Intangibles rose 50.47% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.7 million, marking a year-over-year change of. This contributed to the annual value of $8.0 million for FY2024, which is N/A change from last year.
  • BridgeBio Pharma's Change in Intangibles amounted to $2.4 million in Q3 2025, which was down 46.67% from $4.5 million recorded in Q2 2025.
  • BridgeBio Pharma's Change in Intangibles' 5-year high stood at $4.5 million during Q2 2025, with a 5-year trough of $797,000 in Q1 2024.
  • Moreover, its 2-year median value for Change in Intangibles was $2.4 million (2024), whereas its average is $2.4 million.
  • Data for BridgeBio Pharma's Change in Intangibles shows a peak YoY skyrocketed of 100.13% (in 2025) over the last 5 years.
  • BridgeBio Pharma's Change in Intangibles (Quarterly) stood at $3.2 million in 2024, then soared by 50.47% to $2.4 million in 2025.
  • Its Change in Intangibles stands at $2.4 million for Q3 2025, versus $4.5 million for Q2 2025 and $1.6 million for Q1 2025.